TY - JOUR
T1 - Incidence of hospital-acquired influenza in adults
T2 - A prospective surveillance study from 2004 to 2017 in a French tertiary care hospital
AU - El Guerche-Séblain, Clotilde
AU - Amour, Sélilah
AU - Bénet, Thomas
AU - Hénaff, Laetitia
AU - Escuret, Vanessa
AU - Schellevis, François
AU - Vanhems, Philippe
N1 - Funding Information:
The study was funded by Sanofi Pasteur and a grant from ?Programme Hospitalier de Recherche Clinique R?gional?, PHRC, French Ministry of Health. Sanofi Pasteur funded this study and was involved in the study design, analysis, and interpretation of data, the writing of the report; and in the decision to submit the paper for publication. All authors had full access to all the data in the study and had final responsibility for the decision to submit for publication.Conflicts of interest: CEG is an employee of Sanofi Pasteur, which is developing vaccines against Influenza. SA, TB, LH, VE, FS have no competing interest to declare. PV received grants from French Ministry of Health (2008-2010), grants from Sanofi (2004-2008), during the conduct of the study.
Funding Information:
The study was funded by Sanofi Pasteur and a grant from “ Programme Hospitalier de Recherche Clinique Régional ”, PHRC, French Ministry of Health . Sanofi Pasteur funded this study and was involved in the study design, analysis, and interpretation of data, the writing of the report; and in the decision to submit the paper for publication. All authors had full access to all the data in the study and had final responsibility for the decision to submit for publication.
Publisher Copyright:
© 2020 Association for Professionals in Infection Control and Epidemiology, Inc.
PY - 2021/8
Y1 - 2021/8
N2 - Background: Hospital-acquired influenza potentially leads to significant morbidity and mortality in already vulnerable patients, but its overall burden is not fully understood. We undertook this study to estimate the incidence and trends of hospital-acquired laboratory-confirmed influenza among adults, and to compare clinical characteristics between hospital-acquired and community-acquired influenza cases. Methods: This was a prospective surveillance study over 11 years of adults with influenza-like-illness (ILI) hospitalized in surgery, medicine and geriatric wards in a tertiary acute-care hospital in Lyon, France. Nasal swabs were systematically collected from those with ILI and tested for influenza by reverse transcriptase-polymerase chain reaction at the national influenza reference laboratory (Lyon, France). Results: Influenza was laboratory confirmed at a rate of 1 in 13 patients who developed ILI during their hospitalization. Having an underlying disease was an important characteristic of hospital-acquired ILI cases. Cardiovascular disease was the most frequent underlying condition in both influenza-positive and influenza-negative patients. Complications were more frequent for influenza-positive than influenza-negative patients. The influenza incidence rate was highest in the geriatric ward and increased over the study period. Conclusions: Hospital-acquired influenza poses a significant risk to already vulnerable patients. Longitudinal surveillance data are essential to support better recognition and monitoring of viral infections in hospitals.
AB - Background: Hospital-acquired influenza potentially leads to significant morbidity and mortality in already vulnerable patients, but its overall burden is not fully understood. We undertook this study to estimate the incidence and trends of hospital-acquired laboratory-confirmed influenza among adults, and to compare clinical characteristics between hospital-acquired and community-acquired influenza cases. Methods: This was a prospective surveillance study over 11 years of adults with influenza-like-illness (ILI) hospitalized in surgery, medicine and geriatric wards in a tertiary acute-care hospital in Lyon, France. Nasal swabs were systematically collected from those with ILI and tested for influenza by reverse transcriptase-polymerase chain reaction at the national influenza reference laboratory (Lyon, France). Results: Influenza was laboratory confirmed at a rate of 1 in 13 patients who developed ILI during their hospitalization. Having an underlying disease was an important characteristic of hospital-acquired ILI cases. Cardiovascular disease was the most frequent underlying condition in both influenza-positive and influenza-negative patients. Complications were more frequent for influenza-positive than influenza-negative patients. The influenza incidence rate was highest in the geriatric ward and increased over the study period. Conclusions: Hospital-acquired influenza poses a significant risk to already vulnerable patients. Longitudinal surveillance data are essential to support better recognition and monitoring of viral infections in hospitals.
KW - Epidemiological burden
KW - Longitudinal study
KW - Nosocomial
KW - Respiratory infection
UR - http://www.scopus.com/inward/record.url?scp=85098220544&partnerID=8YFLogxK
U2 - 10.1016/j.ajic.2020.12.003
DO - 10.1016/j.ajic.2020.12.003
M3 - Article
C2 - 33321130
AN - SCOPUS:85098220544
VL - 49
SP - 1066
EP - 1071
JO - American Journal of Infection Control
JF - American Journal of Infection Control
SN - 0196-6553
IS - 8
ER -